Question 1

What is the catalog number for Tafazzin (TAZ, TAZ Protein, Protein G4.5, FLJ27390, EFE2, G4.5) (AP) discontinued?

Accepted Answer

The catalog number for Tafazzin (TAZ, TAZ Protein, Protein G4.5, FLJ27390, EFE2, G4.5) (AP) discontinued is 134201-AP.

Question 2

What sizes are available for Tafazzin (TAZ, TAZ Protein, Protein G4.5, FLJ27390, EFE2, G4.5) (AP) discontinued?

Accepted Answer

Tafazzin (TAZ, TAZ Protein, Protein G4.5, FLJ27390, EFE2, G4.5) (AP) discontinued is available in the following size(s): 100 µL.

Question 3

Is Tafazzin (TAZ, TAZ Protein, Protein G4.5, FLJ27390, EFE2, G4.5) (AP) discontinued in stock?

Accepted Answer

Tafazzin (TAZ, TAZ Protein, Protein G4.5, FLJ27390, EFE2, G4.5) (AP) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Tafazzin (TAZ, TAZ Protein, Protein G4.5, FLJ27390, EFE2, G4.5) (AP) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Anti-Protein S/PROS1 Antibody Picoband® (iFluor647 Conjugate)

Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF647 conjugate, 0.1mg/mL

CD64 (10.1), CF568 conjugate, 0.1mg/mL

CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/2597), Biotin conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 0.2mg/mL

CD134, Mouse (OX40) (OX-86), CF647 conjugate, 0.1mg/mL